Drugs / Fluindione
Fluindione
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy6 trials | ||||||
| Phase 3 | NCT05825573 Comparator | May 2023 → Feb 2025 overdue | ST-elevation myocardial infarction, heart failure, thrombotic disease | Nîmes University Hospital | Active not recruiting | No outcome recorded |
| Phase 3 | NCT02942576 Comparator | Mar 2017 → Sep 2018 | atrial fibrillation | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Completed | No outcome recorded |
| Phase 3 | NCT01674647 Comparator | Oct 2012 → Jan 2014 | atrial fibrillation | Bayer | Completed | No outcome recorded |
| Phase 4 | NCT02227550 Comparator | Dec 2014 → Apr 2017 | atrial fibrillation | Atrial Fibrillation Network | Completed | No outcome recorded |
| Phase 4 | NCT02161965 Comparator | May 2013 → Dec 2016 | atrial fibrillation, pulmonary embolism, venous thromboembolism | University Hospital, Angers | Completed | No outcome recorded |
| Phase 4 | NCT00966290 Comparator | Feb 2003 → Dec 2006 | blood coagulation disease | University Hospital, Toulouse | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluindione | “the VKA type (eg, warfarin, acenocoumarol, phenprocoumon, fluindione, etc) will be assigned by the investigator according to local treatment standards” NCT01674647 ↗5“VKA study medications (Warfarin, Fluindione and Acenocoumarol) will be prescribed and supplied in the usual setting of patient care” NCT05825573 ↗ “Fluindione” NCT02942576 ↗ |
| Known as | 2-(p-fluorophenyl)-1,3-indandione | ChEMBL registry synonym — accepted as the source's own label CHEMBL24924 ↗ |
| Known as | Fluindiona | ChEMBL registry synonym — accepted as the source's own label CHEMBL24924 ↗ |
| Known as | Previscan | ChEMBL registry synonym — accepted as the source's own label CHEMBL24924 ↗ |
| Known as | Previsccan | ChEMBL registry synonym — accepted as the source's own label CHEMBL24924 ↗ |
| Modality | Small molecule | — CHEMBL24924 ↗ |
| Route | Oral | “Adjusted dose of warfarin or fluindione (oral tablet)” NCT02161965 ↗ |